Ampliphi Biosciences Corp (NYSEAMERICAN:APHB – Get Free Report) crossed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $10.55 and traded as low as $8.1650. Ampliphi Biosciences shares last traded at $8.82, with a volume of 59,763 shares changing hands.
Ampliphi Biosciences Trading Down 7.0%
The business has a fifty day moving average of $10.43 and a 200-day moving average of $8.08.
Ampliphi Biosciences Company Profile
Ampliphi Biosciences, Inc is a clinical‐stage biopharmaceutical company headquartered in Cambridge, Massachusetts, focused on the discovery and development of novel therapies to prevent and treat life‐threatening drug‐resistant infections. The company’s core mission is to address the growing global threat of antibiotic resistance by advancing first‐in‐class and best‐in‐class antibacterial agents through late‐stage clinical trials.
The company’s lead product candidate, exeporfinium chloride (XF-73), is a pioneering topical antibacterial designed for pre‐operative nasal decolonization of Staphylococcus aureus in patients undergoing high‐risk surgical procedures.
Featured Articles
- Five stocks we like better than Ampliphi Biosciences
- Viking Sails to All-Time Highs—Fundamentals Signal More to Come
- Datavalut Gains Traction: 5 Reasons to Sell Now
- TMC Stock: Why This Pre-Revenue Miner Is Worth Watching
- The Power Grid Is Dying—Is It Time to Buy Its Replacement?
Receive News & Ratings for Ampliphi Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampliphi Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
